Listed by the USPTO as PETRITSCH, AMANDA MICHELLE
Tech Center 1600 • Art Units: 1612
This examiner grants 57% of resolved cases
PETRITSCH, AMANDA MICHELLE works in tech center 1600 and art unit 1612. The record contains 99 resolved cases, a 56.6% allowance rate, and a median of 1189 days to allowance. The 25.7% interview lift indicates a positive association between interviews and allowance outcomes in this profile.
Colgate-Palmolive Company, The Procter & Gamble Company, and Ethox Chemicals LLC are the leading listed companies. The listed firms are Forge IP, PLLC, SALIWANCHIK, LLOYD & EISENSCHENK, and Thrive IP. The allowance measure and median timeline suggest that practitioners should pair focused interview preparation with careful management of prosecution duration.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18337506 | DENTIFRICE COMPOSITIONS COMPRISING BICARBONATE SALT | Non-Final OA | The Procter & Gamble Company |
| 17577399 | ORAL CARE COMPOSITIONS COMPRISING PEROXIDE AND POLYMER | Non-Final OA | The Procter & Gamble Company |
| 18277596 | AN IMPROVED LONG WEARING SUNSCREEN COSMETIC | Final Rejection | BASF SE |
| 18290064 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE ANIONIC SURFACTANT, ONE AMPHOTERIC OR ZWITTERIONIC SURFACTANT, ONE ASSOCIATIVE POLYMER AND ONE POLYOL | Final Rejection | L'OREAL |
| 18258503 | GELLED AQUEOUS COMPOSITION COMPRISING A HEAVY-GRADE MAGNESIUM SALT | Final Rejection | L'OREAL |
| 18557674 | LIQUID COMPOSITION | Final Rejection | SHISEIDO COMPANY, LTD. |
| 19018357 | Peroxymonosulfate Oral Whitening Compositions | Non-Final OA | Colgate-Palmolive Company |
| 18250421 | Films and Oral Care Compositions | Final Rejection | Colgate-Palmolive Company |
| 17869203 | Oral Care Compositions | Final Rejection | Colgate-Palmolive Company |
| 17826961 | Oral Care Compositions and Methods | Non-Final OA | Colgate-Palmolive Company |
| 17727435 | Solid Oral Care Compositions | Final Rejection | Colgate-Palmolive Company |
| 18002531 | REDUCTION OF UNDESIRABLE TASTE NOTES IN ORAL CARE PRODUCTS | Non-Final OA | Firmenich SA |
| 18682313 | SILVER COMPLEX FLUORIDE {BIS (1,3,5-TRIAZA-7-PHOSPHAADAMANTANE) SILVER FLUORIDE} - A NEW THERAPEUTIC AGENT FOR CARIES MANAGEMENT | Final Rejection | THE UNIVERSITY OF HONG KONG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy56.6% of resolved applications examined by Amanda Michelle Petritsch were allowed (99 resolved cases), compared with 40.7% across Art Unit 1612 over the last five years.
This examiner's interview lift is +25.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Amanda Michelle Petritsch took 1,189 days on average from filing to allowance.
Amanda Michelle Petritsch examines applications in Art Unit 1612 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
